Empower Pharmacy is in trouble with the FDA. Is Your GLP-1 Supplier Next?
Dr. Kate DeePublished on: 02/10/2026
The FDA sent Empower Pharmacy a third warning letter in 18 months over compounded GLP-1s. What it means for medspas prescribing semaglutide and tirzepatide.
compounded GLP-1compounded semaglutidecompounded tirzepatideEmpower PharmacyFDA warning lettercompounding pharmacymedspa compliancemedspa weight loss